Breast Cancer — Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Citation(s)
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors